Literature DB >> 18366177

Determination of protein-ligand binding modes using complexation-induced changes in (1)h NMR chemical shift.

Marina Cioffi1, Christopher A Hunter, Martin J Packer, Andrea Spitaleri.   

Abstract

A new method for determining three-dimensional solution structures of protein-ligand complexes using experimentally determined complexation-induced changes in (1)H NMR chemical shift (CIS) is introduced. The method has been validated using the complex formed between the protein antitumor antibiotic neocarzinostatin (NCS) and a synthetic chromophore analogue. The X-ray crystal structure of the unbound protein and the backbone amide proton CIS were the input data used in the determination of the three-dimensional structure of the complex. The experimental CIS values were used in a continuous direct structure refinement process based on genetic algorithms to sample conformational space. The calculated structure of the complex agrees well with the NMR solution structure, indicating the potential of this approach for structure determination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18366177     DOI: 10.1021/jm701194r

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Use of quantitative (1)H NMR chemical shift changes for ligand docking into barnase.

Authors:  Marina Cioffi; Christopher A Hunter; Martin J Packer; Maya J Pandya; Mike P Williamson
Journal:  J Biomol NMR       Date:  2008-11-01       Impact factor: 2.835

2.  Structure of trans-resveratrol in complex with the cardiac regulatory protein troponin C.

Authors:  Sandra E Pineda-Sanabria; Ian M Robertson; Brian D Sykes
Journal:  Biochemistry       Date:  2011-01-27       Impact factor: 3.162

3.  Protein-ligand structure guided by backbone and side-chain proton chemical shift perturbations.

Authors:  Clémentine Aguirre; Tim ten Brink; Olivier Cala; Jean-François Guichou; Isabelle Krimm
Journal:  J Biomol NMR       Date:  2014-09-26       Impact factor: 2.835

4.  Discovery of fragment molecules that bind the human peroxiredoxin 5 active site.

Authors:  Sarah Barelier; Dominique Linard; Julien Pons; André Clippe; Bernard Knoops; Jean-Marc Lancelin; Isabelle Krimm
Journal:  PLoS One       Date:  2010-03-17       Impact factor: 3.240

5.  Target flexibility: an emerging consideration in drug discovery and design.

Authors:  Pietro Cozzini; Glen E Kellogg; Francesca Spyrakis; Donald J Abraham; Gabriele Costantino; Andrew Emerson; Francesca Fanelli; Holger Gohlke; Leslie A Kuhn; Garrett M Morris; Modesto Orozco; Thelma A Pertinhez; Menico Rizzi; Christoph A Sotriffer
Journal:  J Med Chem       Date:  2008-09-12       Impact factor: 7.446

Review 6.  Fragment-based drug discovery using NMR spectroscopy.

Authors:  Mary J Harner; Andreas O Frank; Stephen W Fesik
Journal:  J Biomol NMR       Date:  2013-05-18       Impact factor: 2.835

7.  Comparing binding modes of analogous fragments using NMR in fragment-based drug design: application to PRDX5.

Authors:  Clémentine Aguirre; Tim ten Brink; Jean-François Guichou; Olivier Cala; Isabelle Krimm
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

8.  BcL-xL conformational changes upon fragment binding revealed by NMR.

Authors:  Clémentine Aguirre; Tim Ten Brink; Olivier Walker; Florence Guillière; Dany Davesne; Isabelle Krimm
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

9.  A Step toward NRF2-DNA Interaction Inhibitors by Fragment-Based NMR Methods.

Authors:  Sven Brüschweiler; Julian E Fuchs; Gerd Bader; Darryl B McConnell; Robert Konrat; Moriz Mayer
Journal:  ChemMedChem       Date:  2021-10-08       Impact factor: 3.540

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.